In low- and middle-income countries, visual inspection with acetic acid (VIA) is used as a low-cost alternative to cytology in cervical cancer screening. But for HIV-positive women, VIA provides suboptimal screening results; to mitigate this screening barrier, researchers aimed to establish the feasibility of screening with VIA plus digital cervicography with real-time consultation (VIA-DCRC) using smartphones to obtain high-quality images. This study, published in Gynecologic Oncology Reports, compares the screening performances of VIA alone versus VIA-DCRC for HIV-positive women. ...
HIV
Advertisement
Targeted discovery proteomics and transcriptomics approaches were used.
A plant-based diet may reduce cardiovascular risk in people with HIV.
Greater than half of infants insured with Medicaid who were diagnosed with HIV not receive preventative treatment.
There are significant challenges in achieving diabetes control in patients with both diabetes and HIV.
A two-dose schedule administered just one week apart can potentially increase the efficacy of an HIV vaccine.
A study used a novel combination approach to increase understanding of the negative effect efavirenz has on the brain.
Metformin may help deplete the viral reservoir and eliminate it in people living with HIV undergoing antiretroviral therapy.
The study will provide HIV prevention, diagnosis, and treatment for incarcerated people with opioid use disorder.
An experimental drug originally developed to treat cancer shows potential in clearing HIV from infected cells in the brain.
Lisa Barr discusses what's being done to bring us closer to an HIV-free future.
Having a strong social support system is vital to the health and well-being of older adults with HIV.
The artificial intelligence chatbot ChatGPT can help Black women educate themselves on HIV prevention anonymously.
The LGBTQ dating app Grindr allegedly sold the private information of its users, including HIV status, to advertisers.
A lack of the small protein interferon-β can compromise brain function in patients with HIV.
A nanofluidic implant delivered an HIV drug with superior potency compared with oral and other HIV drugs.
Advertisement
Expert Interviews on Infectious Disease
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest HIV research and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.